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Procedure TnT < 0.1 0.1-0.2 >0.2
Abdom. Aortic Aneur. 39 (66%) 13 (22%) 7{12%)
Other vascular 160 (79%) 20(10%) 23(11%)
Thoracic 75 (64%) 30 (26%) 12(10%)
Abdominal 99 (89%) 8( 7%) 4( 4%)
Orthopedic 304 (92%) 16( 5%) 12( 4%)
Other 180 (87%) 16( 8%) 10( 5%)
8.1*
4.6
Total
4.3*
1.9
Mortality
Cardiac
38*
27
Lp(a) is a Predictor of Coronary Artery Disease in
Pre-menopausal but not in Post-menopausal
Women
LIPIDS - CLINICAL AND BASIC
Low Total Cholesterol is Associated with Higher
Mortality in Patients with Coronary Heart Disease
Serum Cholesterol and Lipoprotein
Concentrations in Black Bears
1 901-85 1
Low T-C (n ~ 554)
Others (n ~ 13199)
ABSTRACfS 25A
Conclusions: Although data from RHC adds statistically significant infor-
mation to standard clinical and LHC measures, the magnitude is small (12%
of total prognostic information available) and probably does not justify RHC
as routine preoperative investigation.
Elevated serum cholesterol (CHOL) concentration and low HDL concentra-
tion are linked to the development of atherosclerotic heart disease (AHD).
High CHOL levels have been reported in both denning and non-denning
bears, yet coronary artery atherosclerosis has not been observed. Lipopro-
Timothy Floyd, David Garshelis. Ursine Bone Research Laboratory, Hailey, 10;
Minnesota Department of Natural Resources, Grand Rapids, MN
*p < 0.001
Multivariate logistic analysis adjusting for age, gender, past history, clinical
and laboratory findings, yielded a relative risk for total mortality among pts.
with low TC of 1.48 (90% Confidence Interval 1.14-1.93).
Conclusion: In this large group of pts with CAD, low TC was associated
with excess total and cardiac mortality. Longer follow-up and further investi-
gation are necessary to clarify the meaning of this association.
Pts group
Satoshi Sunayarna, Hiroshi Mokuno, Hiroshi Miyano, Hisashi Yokoi. Hiroyuki Daida,
Hiroshi Yamaguchi. Juntendo University, Department of Cardiology, Tokyo, Japan
Coronary artery disease (CAD) risk increases in women after menopause.
Although numerous reports suggest that lipid profile worsening after
menopause may be associated with an increase in CAD among women,
there have been few studies that discussed the contribution of Lp(a). To ex-
amine the association between CAD and Lp(a) in pre-menopausal (PR, <55
yo) and post-menopausal (pO, 0::55 yo) women, we evaluated Lp(a) levels
and other risk factor prevalence in 180 female patients 120 to 77 yo) with an-
giographically defined CAD. Six risk factors were assessed: hyper-Lpla)emia
(Hi-Lp(a), Lpla) 0:: 30 mg/dl). hyper-LDLemia (Hi-LDL, LDL 2: 160 mg/dl), hypo-
HDLemia (Lo-HDL, HDL < 35 mg/dl), hypertension, diabetes, and smoking.
Cases were defined as those who had 2: 1 coronary artery with >50% steno-
sis. There were more patients with Hi-Lp(a) (61 %* vs 27%), Hi-LDL (61 %**
vs 5%) and smoking (61 %** vs 9%) in PR cases (n = 18) as compaved with
those in PR controls (n = 22). PO cases (n ~ 93) had more Lo-HDL (15%*
vs 2%), diabetes (33%** vs 13%) and smokers (61 %** vs 9%) than PO con-
trols (n = 47) did. The median Lp(a) of PR cases was higher than that of PR
controls (38.8*,22.7 mg/dl), and they increased with number of diseased ar-
teries. In contrast, there was no difference in the Lp(a) levels between PO
cases and PO controls 121.7,25.2 mg/dl). Logistic regression model also re-
vealed that Hi-Lp(a) was an independent predictor of CAD after controlling
for Hi-LDL, Lo-HDL. hypertension, diabetes and smoking among PR IB =
2.44, SE = 1.20, P < 0.051. but not among PO. Our data suggests that Lp(a)
may be a strong risk factor for CAD in pre-menopausal women, and in post-
menopausal women other risk factors, such as an estrogen deficiency, may
play an important role. (*p < 0.05, **p < 0.01).
Solomon Behar, Un Goldbourt, Eran Graff, Henrietta Reicher-Reiss,
Valentina Boyko, Michal Benderly, Avi Shotan, Daniel Brunner, BIP Study Group.
Neufeld Cardiac Research Institute, Sheba Medical Center, Tel Hashomer, Israel
Several studies have shown an association between low total cholesterol
(TC) and increased mortality. Among 13,753 patients (pts) of both genders
with coronary artery disease (CAD) aged 45-70 yrs (mean 61 yrs) screened
for the Bezafibrate Infarction Prevention (BIP) Study, 554 pts (4.0%) had low
TC (:::160 mg/dl) mean (147 ± 12 mg/dl). Age, clinical findings and medical
treatments were similarin ptswith 10wTC and pts with TC > 160 mg/dl (mean
222 ± 36 mg/dl). The former had lower mean HDL-C (32.5 ± 8.6 mg/dl) and
triglyceride levels (119 ± 66 mg/dl) in comparison to pts with TC > 160 mg/dl
(37.9 ± 10.0 mg/dl and 164 ± 93 mg/dl respectively) Three year mortality
rates after screening were as follows for both groups:
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Troponin T and Perioperative Ischemia in
Noncardiac Surgery
Thomas H. Lee, Eric J. Thomas, Paula A. Johnson, Lynn E. Ludwig, David Sacks,
Lee Goldman. Brigham and Women's Hospital and Harvard Medical School, Boston,
MA
Prognostic Value of Right Heart Catheterization
Hemodynamic Data in Surgically Treated Patients
with Coronary Artery Disease
William R. Hathaway, Steven E. McNulty, Karen Pieper, Frank E. Harrell. Jr., Daniel
B. Mark, Robert H. Jones, Thomas M. Bashore, Robert M. Califf, Christopher
M. O'Connor. Duke University Medical Center, Durham, NC
Age yrs (median)
To evaluate troponin T (TnT) as a marker for perioperative ischemia, we
prospectively studied 1028 patients (PTS) undergoing major noncardiac
procedures. Clinical data included preoperative examinations, daily clinical
follow-up, and serial electrocardiograms, CK/CK-MB, and TnT levels. Ma-
jor cardiac complications (CaMPS) were classified by reviewers blinded to
TnT data in 29 (3%) of PTS, inclUding acute myocardial infarction (AMII. pul-
monary edema, cardiac arrest, complete heart block, and sustained ventric-
ular tachycardia or fibrillation. AMI was diagnosed using CK-MB criteria in
14 (1.4%) PTS, for whom peak TnT levels were >0.1 mcg~ in 86% and >0.2
mcg/I in 62%. No postoperative clinical complications occurred to the two
PTS with CK-MB criteria for AMI but normal TnT levels. Among the 1014 PTS
without CK-MB criteria for AMI, CaMPS occurred in 5 (0.6%) of 855 PTS
with TnT S 0.1 mcgll versus 10 (6%) of 159 with higher peak TnT levels (p
< 0.0001). This table shows the distribution of peak TnT levels by procedure
type:
We conclude that Tnt correlates with rates of CaMP after major noncar-
diac surgery even among PTS without AMI by CK-MB criteria. In this cohort,
elevated TnT levels were more common with procedures generally associ-
ated with a higher risk of CaMPS. Long term follow-up is needed to de-
termine whether elevated TnT levels in patients without CaMPS were false
positive results or subclinical ischemic events.
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Routine right heart catheterization (RHC) provides limited prognostic infor-
mation in medically treated patients with coronary artery disease. The use
of this procedure in patients undergoing coronary artery bypass grafting has
been more widely advocated. To determine the value of this practice, we
investigated the added prognostic content of hemodynamic data obtained
from 11 RHC variables in 1054 consecutive surgically treated patients (pts)
with significant coronary artery disease (0::75% stenosis) between 8/6/69 and
1/1/80. During this period, RHC was performed routinely on all patients un-
dergoing left heart catheterization (LHC). Follow up was 97% complete. Uni-
variate RHC predictors of survival included pulmonary vascular resistance
(PVR). right atrial mean (RAMI. CO, CI, AV02 difference, RV systolic pressure,
PA systolic, mean and diastolic pressures, and pulmonary capillary wedge
pressure (p < 0.0001 for each).
ng base/mL. No significant differences between ranolazine and placebo were
observed at trough with mean ranolazine plasma levels ranging from 235 to
514 ng base/mL. No clinically meaningful hemodynamic changes or adverse
events occurred with ranolazine compared with placebo. In summary, ra-
nolazine was well tolerated over a wide range of plasma levels. Ranolazine
increased exercise times with no detectable effect on cardiac hemodynam-
ics in patients with chronic stable angina taking other antianginal drugs.
Male
EF (median)
Hx of CHF
PriorMI
LVEDP (median)
1901-841
Using a Cox model the independent predictive value of each RHC vari-
able was analyzed when added to a prognostic model derived from clini-
cal and LHC data. RAM (x 2 = 18.5, P < 0.001) and PVR (x 2 = 8.45, P <
0.001) added independent information to the standard clinical and invasive
(left heart) prognostic factors. A significant interaction was found between
PVR and EF Ip = 0.0067) indicating that elevated PVR contained more prog-
nostic information in patients with normal or elevated EF.
MOLECULAR BIOLOGY/RECEPTORS/HORMONES
Mutation Prognosis No. of Families
Arg719 Trp malignant 4 (3.3% of total)
Arg403Gln malignant 3 (2.5% of totall
Arg453CYs malignant 3 (2.5% of total)
Leu908Vai benign 2(1.6% of total)
Val606 Met benign 1 (0.8% of total)
GI/41 Arg benign 1(0.8% of total)
ISO PSP (mmHg) dP/dtmin (mmHg/s) Tau (msec)
C TG C TG C TG
basal 70 ± 3 70 ± 3 -3042 ± 196 -4766 ± 356 13.6 ± 15 8.2 ± 05
p' ns <0.001 <0.005
0.01 ng gO ± 5 85 ± 5 -4233 ± 226 -6258 ± 628 13.4 ± 1.1 9.3 ± 07
p' ns <0.01 <0.01
1 ng 97 ± 5 79 ± 3 -5223 ± 655 -5434 ± 474 12.5 ± 1.4 99 ± 0.05
p' <001 os ns
Enhanced Myocardial Relaxation In Vivo in
Transgenic Mice Overexpressing the
,B2-Adrenergic Receptor
Howard A. Rockman, RaeAnn Hamilton, Carmela A. Milano, Valmik Bhargava,
Lan Mao, Robert J. Lefkowitz. HHMI, Duke University, Durham, NC; University of
California, San Diego, LaJolla, CA
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PSP = LV peak systolic pressure, Tau calculated using a mono-exponential model with
zero asymptote.• ANOVA C YS. TG
In conclusion, overexpression of ,8rADR resulted in a significant reduc-
tion in LV dP/dtmin associated with a shortening of Tau which was largely
unaffected by ISO infusion. This suggests markedly enhanced myocardial
relaxation in vivo which is most likely due to increased Ca2+ uptake into the
sarcoplasmic reticulum.
We have previously shown that the inotropic state of the intact mouse can
be significantly increased with overexpression of the ,82-adrenergic recep-
tor (,8rADR). However whether processes involving myocardial relaxation
would also be influenced are unknown. Accordingly, transgenic mice that
were created with cardiac-specific overexpression of the ,82-ADR (~200 fold
increase in ,8-ADR density and ~2 fold increase in basal adenylyl cyclase ac-
tivity) were studied using a 2F high fidelity micromanometer placed in the
left ventricle (LV) of anesthetized intact transgenic (TG) (n = 7) and control
(CI (n = 7) mice. Hemodynamic parameters measured were LV pressure,
minimum first derivative of the LV pressure (LV dP/dtmin) and the time con-
stant of isovolumic LV pressure decay(Tau) at baseline and after progressive
doses of isoproterenol (ISO).
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Rapid Genetic Screen for Common ,B-Myosin
Heavy Chain Mutations Causing Familial
Hypertrophic Cardiomyopathy
Antoine B, Abchee, Gottfried Greve, Jonah C. Ifegwu, Alice Joseph,
Linda Bachinski, Robert Roberts. Baylor College of Medicine, Houston, Texas
tein measurements in black bears have not been reported. This study in-
vestigates the concentrations of CHOL and lipoproteins in denning and
non-denning black bears. Serum CHOL concentrations were measured in
1052 serum samples drawn from wild black bears in both the denning and
non-denning states. Non-denning bears were immobilized with ketamine (5
mg/kg) and xylazine (2 mg/kg) whereas denning bears were immobilized with
ketamine (12 mglkg) or tiletamine and zolezapam (4.5 mglkg). Serum total
lipids (TLlP), CHOL and lipoproteins were measured in ten denning bears (4
males, 3 females and 3 lactating females with cubs). CHOL and lipoproteins
also were measured in a non-denning female. Denning bears were fasting
whereas non-denning bears were trapped with high fat content foods and
were non-fasting. Non-denning bears had significantly lower CHOL levels
than denning bears. CHOL levels in denning bears were higher in early winter
(Nov/Dec) than late winter (Feb/Mar). Males had higher CHOL levels than fe-
males during winter, but not during summer. Yearlings had lower CHOL levels
than adults in winter. In the subpopulation of ten denning bears, TliP were
1247 ± 454 mg/dl (range 639-2167); triglycerides (TRIG) were 351 ± 180
mg/dl (range 111-680); CHOL were 376 ± 162 mg/dl (range 175-695); HDL
were 111 ± 35 mg/dl (range 82-185); LDL were 129 ± 66 mg/dllrange 47-
228); and VLDL were 53 ± 22 mg/dl (range 22-87). HDL. LDL and VLDL levels
were not ascertained in three bears because the precipitation technique was
not possible and triglycerides were too high. The CHOL/HDL ratio was 2.8 ±
1.1 (range 1.7-4.8). Values at the lower range for TLiP. TRIG, CHOL, LDL and
VLDL in this subgroup were found in two of the lactating females, who also
had high HDL concentrations. Values for the non-denning female were TRIG
318, CHOL 298, HDL 210, LDL 24, VLDL 64 and CHOL/H DL 1.4. This bear
recently had consumed 10 kgs of bacon. Conclusions: This study confirms
previous reports that CHOL levels are high in black bears, especially during
denning. Further, it demonstrates that, although CHOL, LDL and VLDL con-
centrations were in the range associated with development of human AHD,
the HDL levels were much higher than observed in most human studies. In
fact, the CHOL/HDL ratio was low to low-normal in all bears, including the
bear which had consumed a high fat meal. These data imply that a high HDL
concentration, along with a low CHOllHDL ratio, confers protection against
development of AHD in black bears despite high serum lipid concentrations.
Further investigation could yield information of therapeutic benefit for man.
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Hypertrophic cardiomyopathy (HCM), an autosomal dominant disease and
the most common cause of sudden death in the young, is diagnosed by
echocardiographic detection of cardiac hypertrophy. Unfortunately, the hy-
pertrophy is usually not detectable until adolescence, which may be too late
since sudden death often occurs as the first symptom. The availability of a
clinical genetic assay to detect mutations would provide a definitive diag-
nosis, independent of clinical features and can be made at or before birth.
Computer analysis showed most of the known mutations in the ,8MHC gene
involve a restriction enzyme recognition site which can be exploited as a
rapid genetic screening test. Accordingly, we employed polymerase chain
reaction (PCR) to amplify the involved region of the gene followed by en-
zyme restriction digestion for 15 known mutations in 122 families with HCM.
Fourteen families were positive and 108 negative. Ten families carried one
of the three mutations known to have a high incidence of sudden death with
26 offspring having the mutation and at risk for sudden death while 49 did
not have the mutation and are not at risk of developing HCM. Four families
had one of the three known benign mutations with 23 offspring having the
mutation and 21 without. The mutations were confirmed by sequencing and
shown to be co-inherited with the disease. This test provides for a definitive
genetic diagnosis and identifies those with the mutation and at risk for HCM
and those without who will not develop HCM. Genetic counseling can be
given prior to development of symptoms and those with mutations having
a high incidence of sudden death are candidates for electrophysiology test-
ing and possible implantation of cardiac defibrillators or amiodarone therapy.
The test requires only a blood sample, is simple to perform and results are
available in 48 hours. Over 25 of the ,8MHC mutations have now been shown
to be amenable to rapid genetic diagnosis using PCR and restriction enzyme
digestion.
In Vivo Genetic Engineering of Cardiac Cells:
Intracoronary Administration of Antisense (AS)
Oligonucleotides (ODN)
Kristin E. Ellison, Gary H. Gibbons, Ryuichi Morishita, Michael J. Mann, Robert
S. Kernoff, Victor J. Ozau. Stanford University, Stanford, CA
We have previously documented that transfection of antisense ODN by a
highly efficient Sendai virus (HVJ)-liposome delivery system can be utilized
to modify lesion formation within the peripheral vasculature in vivo. In this
study, we defined the feasibility of modifying cardiac cell gene expression
via a catheter-based coronary infusion of AS ODN in rabbits. The coronary
artery was cannulated via an over-the-wire approach from the carotid artery.
Fluorescein IF)-Iabeled ODN were utilized to evaluate the cellular distribution
and kinetics of ODN uptake within the myocardium after a single intralumi-
nal bolus of HVJ-liposomes containing ODN. Cellular uptake of F-ODN was
primarily localized in the microvasculature and significant staining was also
observed in conduit vessels and cardiac myocytes. Immunohistochemical
analysis verified prominent localization of F-ODN within the microvascular
endothelium. Expression of F-ODN was observed within 10 minutes, peaked
at 1 day, and remained evident for up to one week after transfection by the
HVJ-liposome method. In contrast. F-ODN infused within liposomes without
the viral particle exhibited transient expression that was undetectable within
3 days. These findings indicate that a single intracoronary bolus infusion of
ODN within HVJ-liposomes is a reproducible methodology for delivery of AS
ODN to targeted cells within the myocardium. Future studies will charac-
terize the feasibility of using this approach to modify cardiac structure and
function via regulating myocardial cell gene expression.
